29 results on '"Fung, Henry C"'
Search Results
2. The Impact of Peripheral Stem Cell As a Stem Cell Source on Gvhd for Patients Receiving Post-Transplant High Dose Cyclophosphamide As Gvhd Prophylaxis after an Allogeneic Transplant
3. Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
4. Bloodless Autologous Hematopoeitic Stem Cell Transplant: An Alternative for Jehovah's Witnesses and Others Who Prefer to Go Bloodless
5. Impact of Post-Transplant High-Dose Cyclophosphamide and Donor Sources on CMV Reactivation.
6. Implementing a Four-Day Mobilization Schedule to Accommodate the Demands of a Growing Program with Limited Hours of Operation
7. An Evaluation of Mobilization Efficiency, Efficacy and Toxicity among 3 Different Approaches: Chemomobilization, Chemomobilization with Preemptive Plerixafor Use and Plerixafor with G-CSF as Stem Cell Mobilization (SCM) Strategies in Lymphoid Malignancies
8. CMV and BK Virus Reactivation in Post Transplant Cyclophosphamide (PTCY) after Allogeneic MUD, MRD and Haploidentical Transplant
9. Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes
10. Progressive Disease after Autologous Stem Cell Transplant (ASCT) for Patients with DLBCL in the Rituximab Era: Outcome Analysis and Evaluation of Prognostic Factors
11. GVHD Prophylaxis with Post-Transplant High Dose Cyclophosphamide: Impact on Engraftment, Treatment-Related Mortality and Resource Utilization
12. Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
13. Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?
14. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen
15. Severe Mucositis with Bendamustine Etoposide Ara-C and Melphalan (Be-EAM) As Conditioning Regimen in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (AutoSCT)
16. Graft Versus Host Disease Prophylaxis with a Bortezomib-Based Regimen without G-CSF Support for Patients Undergoing MUD Transplant: Evaluation of Engraftment Kinetics and Transplant Outcomes
17. Long-Term Follow-up and Experience with Donor Lymphocyte Infusion (DLI); Is It Time for a Paradigm Shift?
18. Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day +5 Versus Day +10 Post Autologous Hematopoietic Stem Cell Transplant
19. Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
20. Impact of CD 34 Cell Dose and Conditioning Regimens on Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
21. Stem Cell Mobilization Using the Combination of GCSF (G) and Plerixafor (P) for Lymphoma Patients (pts) Can Overcome the Poor Prognostic Factors That Impact Mobilization Per GITMO Criteria
22. CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1
23. Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone, and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front-Line Therapy for Patients With Follicular or Marginal Zone Lymphoma
24. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice
25. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26−/− mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis
26. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma
27. Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma
28. Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan
29. Training programs in clinical microbiology at the baccalaureate level: Minimal competencies and programmatic approval
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.